MX2015014921A - Compuesto de acido dicarboxilico. - Google Patents
Compuesto de acido dicarboxilico.Info
- Publication number
- MX2015014921A MX2015014921A MX2015014921A MX2015014921A MX2015014921A MX 2015014921 A MX2015014921 A MX 2015014921A MX 2015014921 A MX2015014921 A MX 2015014921A MX 2015014921 A MX2015014921 A MX 2015014921A MX 2015014921 A MX2015014921 A MX 2015014921A
- Authority
- MX
- Mexico
- Prior art keywords
- dicarboxylic acid
- acid compound
- hydrogen atom
- formula
- compound
- Prior art date
Links
- -1 Dicarboxylic acid compound Chemical class 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 201000005991 hyperphosphatemia Diseases 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Es un objeto de la presente invención proporcionar un medicamento para evitar o tratar hiperfosfatemia. Solución: Un compuesto representado por la fórmula general (I) o una sal farmacológicamente aceptable del mismo. (En la fórmula, R1: un grupo metilo o similar, R2: un átomo de hidrógeno o similares, R3: un átomo de hidrógeno o similares, A: un anillo de ciclohexilo o similares, X: CH o similares, Y: CH o similares, Z: CH o similares, y n: 2 o similares.).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013091090 | 2013-04-24 | ||
PCT/JP2014/061390 WO2014175317A1 (ja) | 2013-04-24 | 2014-04-23 | ジカルボン酸化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015014921A true MX2015014921A (es) | 2016-06-02 |
Family
ID=51791887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015014921A MX2015014921A (es) | 2013-04-24 | 2014-04-23 | Compuesto de acido dicarboxilico. |
Country Status (28)
Country | Link |
---|---|
US (2) | US9617232B2 (es) |
EP (1) | EP2990400B1 (es) |
JP (1) | JP5774253B2 (es) |
KR (1) | KR102168259B1 (es) |
CN (3) | CN105121405A (es) |
AU (1) | AU2014258419B2 (es) |
BR (1) | BR112015026840A2 (es) |
CA (1) | CA2909400C (es) |
CY (1) | CY1119296T1 (es) |
DK (1) | DK2990400T3 (es) |
ES (1) | ES2640802T3 (es) |
HK (1) | HK1222385A1 (es) |
HR (1) | HRP20171273T1 (es) |
HU (1) | HUE034554T2 (es) |
IL (1) | IL242195B (es) |
LT (1) | LT2990400T (es) |
MX (1) | MX2015014921A (es) |
MY (1) | MY170262A (es) |
NZ (1) | NZ712660A (es) |
PH (1) | PH12015502429A1 (es) |
PL (1) | PL2990400T3 (es) |
PT (1) | PT2990400T (es) |
RS (1) | RS56243B1 (es) |
RU (1) | RU2662817C2 (es) |
SG (1) | SG11201508542SA (es) |
SI (1) | SI2990400T1 (es) |
TW (1) | TWI594975B (es) |
WO (1) | WO2014175317A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI594975B (zh) * | 2013-04-24 | 2017-08-11 | 第一三共股份有限公司 | 二羧酸化合物 |
CN107074793B (zh) * | 2014-09-26 | 2019-08-23 | 第一三共株式会社 | 二羧酸化合物的盐 |
TW201700458A (zh) * | 2015-04-24 | 2017-01-01 | 第一三共股份有限公司 | 二羧酸化合物之製法 |
EP3529245A4 (en) | 2016-10-24 | 2020-12-23 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THE LATEST |
US11873298B2 (en) | 2017-10-24 | 2024-01-16 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
CA3094527A1 (en) * | 2018-03-23 | 2019-09-26 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
WO2023219127A1 (ja) * | 2022-05-11 | 2023-11-16 | 中外製薬株式会社 | 嚢胞性疾患を治療または予防するための医薬組成物 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ231939A (en) | 1988-12-28 | 1991-07-26 | Takeda Chemical Industries Ltd | Benzothiopyran derivatives and medicaments |
DD280329A1 (de) * | 1989-03-09 | 1990-07-04 | Bitterfeld Chemie | Dispersionsfarbstoffpraeparate zum faerben und bedrucken von polyestermaterialien i |
TW575563B (en) | 1997-08-19 | 2004-02-11 | American Cyanamid Co | Process for the preparation of pyridyl carboxylic amides and esters |
AU2002354410A1 (en) * | 2001-12-05 | 2003-06-17 | Japan Tobacco Inc. | Triazole compound and medicinal use thereof |
AU2003265382A1 (en) * | 2002-08-23 | 2004-03-11 | Pharmacia & Upjohn Company Llc | Antibacterial benzoic acid derivatives |
WO2004085382A1 (ja) * | 2003-03-27 | 2004-10-07 | Kirin Beer Kabushiki Kaisha | 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬 |
FR2872159B1 (fr) | 2004-06-28 | 2007-10-05 | Merck Sante Soc Par Actions Si | Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete |
WO2009157418A1 (ja) * | 2008-06-25 | 2009-12-30 | 第一三共株式会社 | カルボン酸化合物 |
KR20190086591A (ko) | 2009-05-26 | 2019-07-22 | 애브비 아일랜드 언리미티드 컴퍼니 | 암,면역 질환 및 자가면역 질환의 치료를 위한 아폽토시스-유도제 |
DE102009046115A1 (de) | 2009-10-28 | 2011-09-08 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 3-Phenylpropansäuren und ihre Verwendung |
ES2905656T3 (es) | 2010-04-12 | 2022-04-11 | Somalogic Operating Co Inc | Pirimidinas modificadas en posición 5 y su uso |
EA022521B1 (ru) * | 2010-04-28 | 2016-01-29 | Астеллас Фарма Инк. | Соединения тетрагидробензотиофена, фармацевтическая композиция на их основе, их применение и способ лечения гиперфосфатемии |
EP2590656B1 (en) * | 2010-07-07 | 2017-11-15 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
EP2591354B1 (en) | 2010-07-07 | 2016-09-07 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
JP6020460B2 (ja) * | 2011-10-27 | 2016-11-02 | アステラス製薬株式会社 | アミノアルキル置換n−チエニルベンズアミド誘導体 |
WO2013082756A1 (en) * | 2011-12-06 | 2013-06-13 | Leo Pharma A/S | Phosphate transport inhibitors ii |
WO2013082751A1 (en) * | 2011-12-06 | 2013-06-13 | Leo Pharma A/S | Phosphate transport inhibitors i |
WO2014003153A1 (ja) * | 2012-06-28 | 2014-01-03 | 協和発酵キリン株式会社 | 置換アミド化合物 |
TWI594975B (zh) * | 2013-04-24 | 2017-08-11 | 第一三共股份有限公司 | 二羧酸化合物 |
CN107074793B (zh) * | 2014-09-26 | 2019-08-23 | 第一三共株式会社 | 二羧酸化合物的盐 |
-
2014
- 2014-04-21 TW TW103114341A patent/TWI594975B/zh not_active IP Right Cessation
- 2014-04-23 CN CN201480022830.2A patent/CN105121405A/zh active Pending
- 2014-04-23 WO PCT/JP2014/061390 patent/WO2014175317A1/ja active Application Filing
- 2014-04-23 LT LTEP14787530.6T patent/LT2990400T/lt unknown
- 2014-04-23 PT PT147875306T patent/PT2990400T/pt unknown
- 2014-04-23 ES ES14787530.6T patent/ES2640802T3/es active Active
- 2014-04-23 RS RS20170851A patent/RS56243B1/sr unknown
- 2014-04-23 NZ NZ71266014A patent/NZ712660A/en not_active IP Right Cessation
- 2014-04-23 CN CN201710600754.4A patent/CN107311895A/zh active Pending
- 2014-04-23 CN CN201710600302.6A patent/CN107337621A/zh active Pending
- 2014-04-23 DK DK14787530.6T patent/DK2990400T3/da active
- 2014-04-23 JP JP2015513789A patent/JP5774253B2/ja active Active
- 2014-04-23 MY MYPI2015002483A patent/MY170262A/en unknown
- 2014-04-23 BR BR112015026840A patent/BR112015026840A2/pt not_active Application Discontinuation
- 2014-04-23 CA CA2909400A patent/CA2909400C/en not_active Expired - Fee Related
- 2014-04-23 US US14/784,187 patent/US9617232B2/en active Active
- 2014-04-23 SI SI201430269T patent/SI2990400T1/sl unknown
- 2014-04-23 AU AU2014258419A patent/AU2014258419B2/en not_active Ceased
- 2014-04-23 PL PL14787530T patent/PL2990400T3/pl unknown
- 2014-04-23 HU HUE14787530A patent/HUE034554T2/en unknown
- 2014-04-23 RU RU2015150120A patent/RU2662817C2/ru active
- 2014-04-23 KR KR1020157027428A patent/KR102168259B1/ko active IP Right Grant
- 2014-04-23 EP EP14787530.6A patent/EP2990400B1/en active Active
- 2014-04-23 SG SG11201508542SA patent/SG11201508542SA/en unknown
- 2014-04-23 MX MX2015014921A patent/MX2015014921A/es unknown
-
2015
- 2015-10-21 IL IL242195A patent/IL242195B/en active IP Right Grant
- 2015-10-21 PH PH12015502429A patent/PH12015502429A1/en unknown
-
2016
- 2016-09-02 HK HK16110460.2A patent/HK1222385A1/zh not_active IP Right Cessation
- 2016-09-30 US US15/282,384 patent/US9670173B2/en active Active
-
2017
- 2017-08-22 HR HRP20171273TT patent/HRP20171273T1/hr unknown
- 2017-09-06 CY CY20171100944T patent/CY1119296T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015502429A1 (en) | Dicarboxylic acid compound | |
CA2875877C (en) | Syk inhibitors | |
PH12018500065A1 (en) | Oxysterols and methods of use thereof | |
MX2016006336A (es) | Compuestos pirazolopirimidina. | |
PH12015501412A1 (en) | SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR | |
NZ715747A (en) | Syk inhibitors | |
IN2014MN02106A (es) | ||
MX351581B (es) | Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen. | |
MD20140072A2 (ro) | Noi compuşi ai pirolului, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin | |
MY184306A (en) | Compounds for the treatment and prophylaxis of respiratory syncytial virus disease | |
MX2015010354A (es) | Derivados de acido betulinico modificados con aquilo c-3 y alquenilo utiles en el tratamiento de virus de inmunodeficiencia humana (vih). | |
MD4490C1 (ro) | Noi compuşi de indolizină, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin | |
PH12015501993B1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
IN2014DN07509A (es) | ||
IN2012DN00765A (es) | ||
EA201792071A2 (ru) | Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения | |
MX2013008340A (es) | Novedosas 4-amino-n-hidroxi-benzamidas para el tratamiento de cancer. | |
MX364400B (es) | Compuestos de tetraciclina. | |
IN2014CN04449A (es) | ||
MX342153B (es) | Compuestos para el tratamiento y profilaxis de enfermedad por el virus sincitial respiratorio. | |
MX2013002620A (es) | Novedosas n-hidroxi-benzamidas para el tratamiento del cancer. | |
EA201490573A1 (ru) | Соединение бензотиазолона | |
MX2011011716A (es) | Derivados de isoquinolina novedosos. | |
MX2013002694A (es) | Derivados de tetrahidroquinolina usados como activadores de proteina cinasa activada por monofosfato de adenosina. | |
MX2015002705A (es) | Compuestos de piridinona para usarse en terapia fotodinamica. |